Phase 1 dose-escalation study of the heat shock protein 90 inhibitor BIIB021 with trastuzumab in HER2+ metastatic breast cancer Meeting Abstract
| Authors: | Modi, S.; Ismail-Khan, R.; Munster, P.; Lucas, M.; Galluppi, G. R.; Tangri, S.; Chen, Y.; Yamashita, M.; Storgard, C. M.; Moulder, S. |
| Abstract Title: | Phase 1 dose-escalation study of the heat shock protein 90 inhibitor BIIB021 with trastuzumab in HER2+ metastatic breast cancer |
| Meeting Title: | 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 70 |
| Issue: | 24 Suppl. |
| Meeting Dates: | 2010 Dec 9-12 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2010-12-15 |
| Language: | English |
| ACCESSION: | WOS:000209695801291 |
| DOI: | 10.1158/0008-5472.sabcs10-p3-14-02 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P3-14-02 -- Source: Wos |
